Microbleed Patterns in Critical Illness and COVID-19
Overview
Authors
Affiliations
Background: Cerebral microbleeds are increasingly reported in critical ill patients with respiratory failure in need of mechanical ventilation and/or extracorporeal membrane oxygenation (ECMO). Typically, these critical illness-associated microbleeds involve the juxtacortical white matter and corpus callosum. Recently, this pattern was reported in patients with respiratory failure, suffering from COVID-19.
Materials And Methods: In this retrospective single-center study, we listed patients from March 11, 2020 to September 2, 2020, with laboratory-confirmed COVID-19, critical illness and cerebral microbleeds. Literature research was conducted through a methodical search on Pubmed databases on critical illness-associated microbleeds and cerebral microbleeds described in patients with COVID-19.
Results And Discussion: On 279 COVID-19 admissions, two cases of cerebral microbleeds were detected in critical ill patients with respiratory failure due to COVID-19. Based on review of existing literature critical illness-associated microbleeds tend to predominate in subcortical white matter and corpus callosum. Cerebral microbleeds in patients with COVID-19 tend to follow similar patterns as reported in critical illness-associated microbleeds. Hence, one patient with typical critical illness-associated microbleeds and COVID-19 is reported. However, a new pattern of widespread cortico-juxtacortical microbleeds, predominantly in the anterior vascular territory with relative sparing of deep gray matter, corpus callosum and infratentorial structures is documented in a second case. The possible etiologies of these microbleeds include hypoxia, hemorrhagic diathesis, brain endothelial erythrophagocytosis and/or cytokinopathies. An association with COVID-19 remains to be determined.
Conclusion: Further systematic investigation of microbleed patterns in patients with neurological impairment and COVID-19 is necessary.
Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health.
Fekete M, Lehoczki A, Szappanos A, Toth A, Mahdi M, Sotonyi P Geroscience. 2025; 47(1):745-779.
PMID: 39777702 PMC: 11872997. DOI: 10.1007/s11357-024-01487-4.
Jusovic-Stocanin A, Kaemmerer E, Ihle H, Autsch A, Kleemann S, Sanft J Diseases. 2024; 12(10).
PMID: 39452484 PMC: 11506861. DOI: 10.3390/diseases12100241.
COVID-19-associated neurological sequelae: A case series on cerebral microbleeds and encephalopathy.
Safan A, Imam Y, Khatib M, Al Wraidat M, Altermanini M, Al-Mughalles S Qatar Med J. 2023; 2023(4):29.
PMID: 37920783 PMC: 10618109. DOI: 10.5339/qmj.2023.29.
Effects of COVID-19 on cognition and brain health.
Zhao S, Toniolo S, Hampshire A, Husain M Trends Cogn Sci. 2023; 27(11):1053-1067.
PMID: 37657964 PMC: 10789620. DOI: 10.1016/j.tics.2023.08.008.
Cerebral small vessel disease pathology in COVID-19 patients: A systematic review.
Owens C, Pinto C, Detwiler S, Mukli P, Peterfi A, Szarvas Z Ageing Res Rev. 2023; 88():101962.
PMID: 37224885 PMC: 10202464. DOI: 10.1016/j.arr.2023.101962.